The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In-Vitro Cancer Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
In-vitro cancer diagnostics are medical tests and assays used to detect and diagnose cancer using patient samples, such as blood, tissue, or urine.
The global In-Vitro Cancer Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of In-Vitro Cancer Diagnostics in various end use industries. The expanding demands from the Laboratories, Hospitals and Others,, are propelling In-Vitro Cancer Diagnostics market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents and Kits segment is estimated at % CAGR for the next seven-year period.
The market for in-vitro cancer diagnostics is driven by the growing burden of cancer and the need for early and accurate cancer detection. The market's growth is also influenced by the development of novel biomarkers and advanced diagnostic technologies, leading to improved sensitivity and specificity of cancer tests.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In-Vitro Cancer Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In-Vitro Cancer Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In-Vitro Cancer Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In-Vitro Cancer Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In-Vitro Cancer Diagnostics covered in this report include MDx Health Quest Diagnostics, R-Biopharm AG, Signature Diagnostics, Siemens Healthcare, Randox Laboratories, Epigenomics AG, Beckman Coulter, Abbott Laboratories and Burning Rock, etc.
The global In-Vitro Cancer Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
MDx Health Quest Diagnostics
R-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
Burning Rock
Novogene
Geneseeq
Amoy Diagnostics Co.,Ltd.
Daan Gene
Fosun Pharma
Global In-Vitro Cancer Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In-Vitro Cancer Diagnostics market, Segment by Type:
Instruments
Reagents and Kits
Global In-Vitro Cancer Diagnostics market, by Application
Laboratories
Hospitals
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In-Vitro Cancer Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In-vitro cancer diagnostics are medical tests and assays used to detect and diagnose cancer using patient samples, such as blood, tissue, or urine.
The global In-Vitro Cancer Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of In-Vitro Cancer Diagnostics in various end use industries. The expanding demands from the Laboratories, Hospitals and Others,, are propelling In-Vitro Cancer Diagnostics market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents and Kits segment is estimated at % CAGR for the next seven-year period.
The market for in-vitro cancer diagnostics is driven by the growing burden of cancer and the need for early and accurate cancer detection. The market's growth is also influenced by the development of novel biomarkers and advanced diagnostic technologies, leading to improved sensitivity and specificity of cancer tests.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In-Vitro Cancer Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In-Vitro Cancer Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In-Vitro Cancer Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In-Vitro Cancer Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In-Vitro Cancer Diagnostics covered in this report include MDx Health Quest Diagnostics, R-Biopharm AG, Signature Diagnostics, Siemens Healthcare, Randox Laboratories, Epigenomics AG, Beckman Coulter, Abbott Laboratories and Burning Rock, etc.
The global In-Vitro Cancer Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
MDx Health Quest Diagnostics
R-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
Burning Rock
Novogene
Geneseeq
Amoy Diagnostics Co.,Ltd.
Daan Gene
Fosun Pharma
Global In-Vitro Cancer Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In-Vitro Cancer Diagnostics market, Segment by Type:
Instruments
Reagents and Kits
Global In-Vitro Cancer Diagnostics market, by Application
Laboratories
Hospitals
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In-Vitro Cancer Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In-Vitro Cancer Diagnostics
1.1 In-Vitro Cancer Diagnostics Market Overview
1.1.1 In-Vitro Cancer Diagnostics Product Scope
1.1.2 In-Vitro Cancer Diagnostics Market Status and Outlook
1.2 Global In-Vitro Cancer Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In-Vitro Cancer Diagnostics Market Size by Region (2018-2029)
1.4 Global In-Vitro Cancer Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global In-Vitro Cancer Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In-Vitro Cancer Diagnostics Market Size (2018-2029)
1.6.1 North America In-Vitro Cancer Diagnostics Market Size (2018-2029)
1.6.2 Europe In-Vitro Cancer Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2018-2029)
1.6.4 Latin America In-Vitro Cancer Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2018-2029)
2 In-Vitro Cancer Diagnostics Market by Type
2.1 Introduction
2.1.1 Instruments
2.1.2 Reagents and Kits
2.2 Global In-Vitro Cancer Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In-Vitro Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In-Vitro Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In-Vitro Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In-Vitro Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In-Vitro Cancer Diagnostics Revenue Breakdown by Type (2018-2029)
3 In-Vitro Cancer Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Laboratories
3.1.2 Hospitals
3.1.3 Others
3.2 Global In-Vitro Cancer Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In-Vitro Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In-Vitro Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In-Vitro Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In-Vitro Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In-Vitro Cancer Diagnostics Revenue Breakdown by Application (2018-2029)
4 In-Vitro Cancer Diagnostics Competition Analysis by Players
4.1 Global In-Vitro Cancer Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2022)
4.3 Date of Key Players Enter into In-Vitro Cancer Diagnostics Market
4.4 Global Top Players In-Vitro Cancer Diagnostics Headquarters and Area Served
4.5 Key Players In-Vitro Cancer Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 In-Vitro Cancer Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 MDx Health Quest Diagnostics
5.1.1 MDx Health Quest Diagnostics Profile
5.1.2 MDx Health Quest Diagnostics Main Business
5.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Products, Services and Solutions
5.1.4 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 MDx Health Quest Diagnostics Recent Developments
5.2 R-Biopharm AG
5.2.1 R-Biopharm AG Profile
5.2.2 R-Biopharm AG Main Business
5.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Products, Services and Solutions
5.2.4 R-Biopharm AG In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 R-Biopharm AG Recent Developments
5.3 Signature Diagnostics
5.3.1 Signature Diagnostics Profile
5.3.2 Signature Diagnostics Main Business
5.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Products, Services and Solutions
5.3.4 Signature Diagnostics In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Healthcare Recent Developments
5.4 Siemens Healthcare
5.4.1 Siemens Healthcare Profile
5.4.2 Siemens Healthcare Main Business
5.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Products, Services and Solutions
5.4.4 Siemens Healthcare In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Healthcare Recent Developments
5.5 Randox Laboratories
5.5.1 Randox Laboratories Profile
5.5.2 Randox Laboratories Main Business
5.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Products, Services and Solutions
5.5.4 Randox Laboratories In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Randox Laboratories Recent Developments
5.6 Epigenomics AG
5.6.1 Epigenomics AG Profile
5.6.2 Epigenomics AG Main Business
5.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Products, Services and Solutions
5.6.4 Epigenomics AG In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Epigenomics AG Recent Developments
5.7 Beckman Coulter
5.7.1 Beckman Coulter Profile
5.7.2 Beckman Coulter Main Business
5.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Products, Services and Solutions
5.7.4 Beckman Coulter In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Beckman Coulter Recent Developments
5.8 Abbott Laboratories
5.8.1 Abbott Laboratories Profile
5.8.2 Abbott Laboratories Main Business
5.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Products, Services and Solutions
5.8.4 Abbott Laboratories In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Laboratories Recent Developments
5.9 Burning Rock
5.9.1 Burning Rock Profile
5.9.2 Burning Rock Main Business
5.9.3 Burning Rock In-Vitro Cancer Diagnostics Products, Services and Solutions
5.9.4 Burning Rock In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Burning Rock Recent Developments
5.10 Novogene
5.10.1 Novogene Profile
5.10.2 Novogene Main Business
5.10.3 Novogene In-Vitro Cancer Diagnostics Products, Services and Solutions
5.10.4 Novogene In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Novogene Recent Developments
5.11 Geneseeq
5.11.1 Geneseeq Profile
5.11.2 Geneseeq Main Business
5.11.3 Geneseeq In-Vitro Cancer Diagnostics Products, Services and Solutions
5.11.4 Geneseeq In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Geneseeq Recent Developments
5.12 Amoy Diagnostics Co.,Ltd.
5.12.1 Amoy Diagnostics Co.,Ltd. Profile
5.12.2 Amoy Diagnostics Co.,Ltd. Main Business
5.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Products, Services and Solutions
5.12.4 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Amoy Diagnostics Co.,Ltd. Recent Developments
5.13 Daan Gene
5.13.1 Daan Gene Profile
5.13.2 Daan Gene Main Business
5.13.3 Daan Gene In-Vitro Cancer Diagnostics Products, Services and Solutions
5.13.4 Daan Gene In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Daan Gene Recent Developments
5.14 Fosun Pharma
5.14.1 Fosun Pharma Profile
5.14.2 Fosun Pharma Main Business
5.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Products, Services and Solutions
5.14.4 Fosun Pharma In-Vitro Cancer Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Fosun Pharma Recent Developments
6 North America
6.1 North America In-Vitro Cancer Diagnostics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe In-Vitro Cancer Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In-Vitro Cancer Diagnostics Market Dynamics
11.1 In-Vitro Cancer Diagnostics Industry Trends
11.2 In-Vitro Cancer Diagnostics Market Drivers
11.3 In-Vitro Cancer Diagnostics Market Challenges
11.4 In-Vitro Cancer Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
